XingImaging Launches Cutting-Edge Research Facility in New Haven, Connecticut
XingImaging Unveils New Facility in New Haven
XingImaging, a notable name in advanced imaging and radiopharmaceutical services, has officially opened a state-of-the-art research facility in New Haven, Connecticut. This innovative center is designed to enhance the capabilities of clinical research and development in the healthcare sector.
The newly inaugurated facility features several advanced technologies, including clinical evaluation spaces for participant recruitment in clinical studies, cutting-edge cGMP radiochemistry labs, and imaging equipment comprising 2 PET-CT and 1 SPECT-CT scanners. These investments reflect the company’s commitment to being at the forefront of research imaging.
One notable highlight is the incorporation of the NeuroExplorer PET scanner from United Imaging, heralded as the world’s first ultra-high-performance brain PET scanner. This piece of technology provides unmatched resolution and sensitivity, allowing researchers to delve deeper into brain functions and disorders such as Parkinson's and Alzheimer's diseases. With a resolution of 1.4 mm and sensitivity of 46 kcps/MBq, it delivers remarkable imaging quality, even for the most intricate brain structures.
Gilles Tamagnan, the CEO of XingImaging, expressed enthusiasm about this new chapter for the company: "We are proud to open this facility in New Haven, a hub for research and healthcare innovation. It not only symbolizes our commitment to high-quality imaging solutions but also aims to accelerate the development of life-saving treatments. The addition of the NeuroExplorer PET camera exemplifies our dedication to scientific innovation."
The facility’s services are comprehensive, including:
- - Clinical Trial Services: A seamless clinic aimed at delivering compassionate and top-notch services tailored to support clinical trials.
- - Advanced Imaging Services: Utilizing state-of-the-art imaging technology with a robust focus on precision, quality, and reliability.
- - Radiotracer Manufacturing: Customized GMP production that caters to the strict requirements of clinical trials while adhering to rigorous quality standards.
- - Imaging Analysis Services: Specialized analysis pipelines that prioritize maximizing signal-to-noise ratios and ensuring reproducibility in results.
With these upgrades, XingImaging is poised not only to facilitate superior research but also to offer high-value services to pharmaceutical and biotech partners. The focus on quality and precision in all facets of operation ensures that participants and collaborators receive nothing short of excellence in service.
XingImaging stands as a beacon of advanced research capabilities in the healthcare landscape, enabling breakthroughs in medical diagnostics and treatment through its affiliation with MITRO, a global leader in molecular imaging and contract research. This synergy aims to transform the landscape of clinical trials and medical research into one marked by speed, accuracy, and innovation.
To learn more about XingImaging and their range of services, feel free to visit www.xingimaging.com or reach out via email at [email protected].
About XingImaging
XingImaging, a subsidiary of MITRO, specializes in advanced research imaging and radiopharmaceutical services. Upholding high industry standards, it partners with pharmaceutical and biotech organizations, striving to pave the way for significant advancements in medical science.
About MITRO
MITRO is a leading molecular imaging contract research organization based in China, dedicated to enhancing new drug development through radiolabeling and imaging techniques. The merger with XingImaging in 2023 has created a robust entity committed to offering comprehensive CRO and CDMO services.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.